Mario E. Lacouture

Dermatology

1111 Franklin Ave
Garden City, NY 11530

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 283 publications

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.

Journal: Nature medicine

Published: September 02, 2026

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Journal: Journal of drugs in dermatology : JDD

Published: July 06, 2026

Skin Abnormalities at Checkpoint Inhibitor Therapy Initiation Are Associated With Skin Rash Development in Oncology Patients.

Skin Abnormalities at Checkpoint Inhibitor Therapy Initiation Are Associated With Skin Rash Development in Oncology Patients.

Journal: Allergy

Published: March 17, 2026

Sparse insurance and alopecia information availability among New York City wig providers: A cross-sectional study.

Sparse insurance and alopecia information availability among New York City wig providers: A cross-sectional study.

Journal: Journal of the American Academy of Dermatology

Published: February 25, 2026

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Journal: Journal for immunotherapy of cancer

Published: February 10, 2026

Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer.

Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer.

Journal: JAMA network open

Published: January 06, 2026

Antimicrobial Exposure and Immune-Related Cutaneous Adverse Events During Immune Checkpoint Blockade Therapy.

Antimicrobial Exposure and Immune-Related Cutaneous Adverse Events During Immune Checkpoint Blockade Therapy.

Journal: JAMA dermatology

Published: December 17, 2025

Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial Chemotherapy.

Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial Chemotherapy.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 23, 2025

Response to Kim et al "Legislative efforts to expand insurance coverage of wigs for individuals with medical causes of alopecia".

Response to Kim et al "Legislative efforts to expand insurance coverage of wigs for individuals with medical causes of alopecia".

Journal: Journal of the American Academy of Dermatology

Published: October 20, 2025

Patient Perspectives regarding Artificial Intelligence-Driven Trichoscopy for Alopecia Evaluation.

Patient Perspectives regarding Artificial Intelligence-Driven Trichoscopy for Alopecia Evaluation.

Journal: Skin appendage disorders

Published: September 30, 2025

Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial.

Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 29, 2025

Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer.

Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer.

Journal: ESMO open

Published: July 23, 2025

Showing 1-12 of 283

Last Updated: 09/26/2026